These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 20148792)

  • 1. How ideology shapes the evidence and the policy: what do we know about cannabis use and what should we do?
    Macleod J; Hickman M
    Addiction; 2010 Aug; 105(8):1326-30. PubMed ID: 20148792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenges in developing a rational cannabis policy.
    Hall W; Lynskey M
    Curr Opin Psychiatry; 2009 May; 22(3):258-62. PubMed ID: 19293714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing the harms caused by cannabis use: the policy debate in Australia.
    Hall W
    Drug Alcohol Depend; 2001 May; 62(3):163-74. PubMed ID: 11295320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What are the policy implications of the evidence on cannabis and psychosis?
    Hall W; Degenhardt L
    Can J Psychiatry; 2006 Aug; 51(9):566-74. PubMed ID: 17007223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critique of cannabis legalization proposals in Canada.
    Kalant H
    Int J Drug Policy; 2016 Aug; 34():5-10. PubMed ID: 27292414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based policy? The re-medicalization of cannabis and the role of expert committees in the UK, 1972-1982.
    Taylor SL
    Int J Drug Policy; 2016 Nov; 37():129-135. PubMed ID: 27477790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in reducing cannabis-related harm in Australia.
    Hall WD
    Drug Alcohol Rev; 2009 Mar; 28(2):110-6. PubMed ID: 19320694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis policy: issues and options.
    Abel S; Casswell S
    N Z Med J; 1998 Sep; 111(1074):367-70. PubMed ID: 11039824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabis policy: time to move beyond the psychosis debate.
    Werb D; Fischer B; Wood E
    Int J Drug Policy; 2010 Jul; 21(4):261-4. PubMed ID: 20381329
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating the public health impacts of legalizing recreational cannabis use in the United States.
    Hall W; Lynskey M
    Addiction; 2016 Oct; 111(10):1764-73. PubMed ID: 27082374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis: high time for evidence-based policies.
    The Lancet Oncology
    Lancet Oncol; 2017 Jan; 18(1):1. PubMed ID: 28049567
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act.
    Monaghan M
    Int J Drug Policy; 2014 Sep; 25(5):1025-30. PubMed ID: 24635973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs and benefits of cannabis control policies
.
    Hall W
    Dialogues Clin Neurosci; 2020 Sep; 22(3):281-287. PubMed ID: 33162771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the harms of cannabis cultivation in Belgium.
    Paoli L; Decorte T; Kersten L
    Int J Drug Policy; 2015 Mar; 26(3):277-89. PubMed ID: 25599596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.
    Davenport S; Pardo B
    Int J Drug Policy; 2016 Nov; 37():60-69. PubMed ID: 27596698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabis and psychomotor performance: a rational review of the evidence and implications for public policy.
    Armentano P
    Drug Test Anal; 2013 Jan; 5(1):52-6. PubMed ID: 22972702
    [No Abstract]   [Full Text] [Related]  

  • 17. Does liberalizing cannabis laws increase cannabis use?
    Williams J; Bretteville-Jensen AL
    J Health Econ; 2014 Jul; 36():20-32. PubMed ID: 24727348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis policy and the uptake of treatment for cannabis-related problems.
    Adam C; Raschzok A
    Drug Alcohol Rev; 2017 Mar; 36(2):171-177. PubMed ID: 27004985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legalization, decriminalization & medicinal use of cannabis: a scientific and public health perspective.
    Svrakic DM; Lustman PJ; Mallya A; Lynn TA; Finney R; Svrakic NM
    Mo Med; 2012; 109(2):90-8. PubMed ID: 22675784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis use in Canada: the need for a 'public health' approach.
    Fischer B; Rehm J; Hall W
    Can J Public Health; 2009; 100(2):101-3. PubMed ID: 19839283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.